Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

Kevin J. Harrington, Robert L. Ferris, George R. Blumenschein, +21

The Lancet Oncology

OncologyNeoadjuvant TherapyCheckmate 141Cancer ManagementClinical Trials +9

Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial

David Cella, Viktor Grünwald, Paul Nathan, +9

The Lancet Oncology

Checkmate 025UrologyGenitourinary CancerMedicineCancer Treatment +2

Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial

Martin Reck, Michael Schenker, Ki Hyeong Lee, +18

European Journal of Cancer

Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy

Michael A. Farrell, Michael DeRosa, John Curran, +6

Acta Neuropathologica

Pediatric NeurosurgeryNeuroanatomyNeuropathologic FindingsIntractable Childhood EpilepsyBrain Injury +9

Impact of Nivolumab versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients with Advanced Squamous Non–Small Cell Lung Cancer: Results from the CheckMate 017 Study

Martin Reck, Fiona Taylor, John R. Penrod, +5

Journal of Thoracic Oncology

Checkmate 017OncologyHealth-related QualityCancer ManagementOutcomes Research +4

Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography

Xinbo Zhang, Nils A. Loewen, Ou Tan, +47

American Journal of Ophthalmology

RetinaMedical ImagingOphthalmologyBiomedical ImagingOptical Coherence Tomography +5

Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057

Martin Reck, Julie R. Brahmer, Bryan Bennett, +6

European Journal of Cancer

Quality Of LifeOncologyHealth-related QualityCancer ManagementOutcomes Research +5

Individual Differences and Cross-Situational Consistency of Dyadic Social Behavior.

Thomas E. Malloy, Suzy Barcelos, Elise Arruda, +2

Journal of Personality and Social Psychology

Unique ResponsesSocial PsychologyIndividual DifferencesDyadic ProcessesSocial Sciences +17

Impact of Pediatric Acute Otitis Media on Child and Parental Quality of Life and Associated Productivity Loss in Malaysia: A Prospective Observational Study

Bruce Crawford, Siti Sabzah Mohd Hashim, Narayanan Prepageran, +6

Drugs - Real World Outcomes

A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions

James W. Shaw, Bryan Bennett, Andrew Trigg, +7

Value in Health

Cancer QualityQuality Of LifeEuropean OrganisationLife AssessmentHealth Economics +10